The different behavior of HE4 compared to CA125 demonstrated in this study could indicate the better clinical sensitivity of this biomarker, thus suggesting its potential application in the surveillance of asymptomatic forms of COVID-19. The gene discussed is WFDC2; the disease is COVID-19.